SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination
Authors
Keywords
-
Journal
BONE MARROW TRANSPLANTATION
Volume 58, Issue 5, Pages 567-580
Publisher
Springer Science and Business Media LLC
Online
2023-03-01
DOI
10.1038/s41409-023-01946-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients
- (2023) José Luis Piñana et al. Blood Cancer Journal
- SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses
- (2022) Alexandra C. Walls et al. CELL
- Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron
- (2022) Juan Manuel Carreño et al. NATURE
- Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
- (2022) Peter B. Gilbert et al. SCIENCE
- Patients with CLL have lower risk of death from COVID-19 in the omicron era
- (2022) Carsten Utoft Niemann et al. BLOOD
- Increased COVID-19 Breakthrough Infection Risk in Patients with Plasma Cell Disorders
- (2022) Jennifer La et al. BLOOD
- Immunity to SARS-CoV-2: What Do We Know and Should We Be Testing for It?
- (2022) Anisha Misra et al. JOURNAL OF CLINICAL MICROBIOLOGY
- SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders
- (2022) José Luis Piñana et al. Journal of Hematology & Oncology
- Determinants of SARS-CoV-2 waning immunity in allogeneic hematopoietic stem cell transplant recipients
- (2022) Mathieu Leclerc et al. Journal of Hematology & Oncology
- Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study
- (2022) Cristina Menni et al. LANCET
- Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9)
- (2022) Simone Cesaro et al. LEUKEMIA
- Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2
- (2022) Yair Goldberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients
- (2022) José Luis Piñana et al. ANNALS OF HEMATOLOGY
- Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections
- (2022) Heba N. Altarawneh et al. NEW ENGLAND JOURNAL OF MEDICINE
- The durability of natural infection and vaccine-induced immunity against future infection by SARS-CoV-2
- (2022) Jeffrey P. Townsend et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Head-to-Head Comparison of 5 Anti-SARS-CoV-2 Assays Performance in One Hundred COVID-19 Vaccinees, over an 8-Month Course
- (2022) Jakub Swadźba et al. Diagnostics
- Efficacy of SARS-CoV-2 primary and booster vaccine doses in CAR-T recipients – targeting the target antigen
- (2022) Bradley S. Uyemura et al. BONE MARROW TRANSPLANTATION
- Further humoral immunity evasion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants
- (2022) Fanchong Jian et al. LANCET INFECTIOUS DISEASES
- Third Early “Booster” Dose Strategy in France of bnt162b2 SARS-CoV-2 Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients Enhances Neutralizing Antibody Responses
- (2022) Abdelhakim Ahmed-Belkacem et al. Viruses-Basel
- A performance comparison of two (electro) chemiluminescence immunoassays for detection and quantitation of serum anti‐spike antibodies according to SARS‐CoV‐2 vaccination and infections status
- (2022) Jorge Camacho et al. JOURNAL OF MEDICAL VIROLOGY
- Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial
- (2022) Youyi Fong et al. Nature Microbiology
- Quantitative measurement of anti-SARS-CoV-2 antibodies: Analytical and clinical evaluation
- (2021) Victoria Higgins et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Comparison of five commercial anti-SARS-CoV-2 total antibodies and IgG immunoassays after vaccination with BNT162b2 mRNA
- (2021) Elisa Danese et al. Journal of Medical Biochemistry
- Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19
- (2021) Nicole Doria-Rose et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey
- (2021) Per Ljungman et al. LEUKEMIA
- Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study
- (2021) Kazimieras Maneikis et al. Lancet Haematology
- SARS‐CoV ‐2‐reactive antibody detection after SARS‐CoV ‐2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group
- (2021) José Luis Piñana et al. AMERICAN JOURNAL OF HEMATOLOGY
- Effectiveness of the BNT162b2mRNA Covid-19 Vaccine in Patients with Hematological Neoplasms
- (2021) Moshe Mittelman et al. BLOOD
- Coronavirus Disease 2019 Messenger RNA Vaccine Immunogenicity in Immunosuppressed Individuals
- (2021) Ai-ris Y Collier et al. JOURNAL OF INFECTIOUS DISEASES
- Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group
- (2021) Anne Mea Spanjaart et al. LEUKEMIA
- Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients
- (2021) José Luis Piñana et al. LEUKEMIA & LYMPHOMA
- Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection
- (2021) Ital Nemet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT
- (2021) Rabah Redjoul et al. Lancet Haematology
- Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies
- (2021) Moraima Jiménez et al. Blood Advances
- Risk factors and outcome of COVID-19 in patients with hematological malignancies
- (2020) José Luis Piñana et al. Experimental Hematology & Oncology
- Correlates of protection against SARS-CoV-2 in rhesus macaques
- (2020) Katherine McMahan et al. NATURE
- Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
- (2020) Alicia T. Widge et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation